The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance (MT) treatment (Tx) after lenalidomide, bortezomib, and dexamethasone (RVD) induction and stem cell transplant (SCT) in high-risk (HR) patients (pts) with newly diagnosed multiple myeloma (NDMM): A real-world analysis.
 
Rafael Fonseca
Honoraria - Amgen; Bayer; Binding Site; Bristol-Myers Squibb; Celgene; Janssen; Lilly; Millennium; Novartis
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bayer; Binding Site; Bristol-Myers Squibb; Celgene; Janssen; Lilly; Millennium; Novartis
Research Funding - Celgene (Inst); Cylene; Onyx
Patents, Royalties, Other Intellectual Property - Dr Fonseca has received a patent for the prognostication of MM based on genetic categorization of the disease.
 
Kejal Parikh
Employment - Celgene
 
Brian Ung
Other Relationship - Celgene
 
Quanhong Ni
Employment - Celgene
 
Amit Agarwal
Employment - Celgene